GLSyntech focuses on chemistry based technologies, products and services that improve the quality of small molecule drug discovery,
development and manufacturing while delivering customer satisfaction, cost performance, and operational excellence.
Meanwhile, GLSyntech is establishing its biocatalyst capability with full access to more than
400 proprietary enzyme
catalysts. It extends greatly its ability in unique chiral transformations in developing and manufacturing both
advanced intermediates and APIs.
With its global facilities in USA and China, and a R&D team of over 100 technically competent chemists and engineers GLSyntech
is well positioned to provide a
comprehensive range of chemistry technologies, products and services cost competitively in the
entire drug development process from lead generation, through early phases of clinical trials, and all the way to API manufacturing.
In addition, GLSyntech has gained many years of experience in bulk manufacturing of unique specialty chemicals,
and their application knowledge. We are fully committed to customerís needs in custom manufacturing and
contract manufacturing of specialty chemicals, with particular interest in new product development jointly with customers.